UnitedHealthcare
Imfinzi (durvalumab)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: NSCLC Systemic Therapy:
    Documented Diagnosis: Yes
    Duration: 12 Month(s)

  • NSCLC Systemic Therapy:
    Duration: 12 Month(s)
    Specialist Required: Yes
    Documented Diagnosis: Yes
    Medical Test Required: No
    Specialist Type(s): Oncologist
    Reauthorization Required: No
    Duration of Reauthorization: N/A